level-one heading

Kolabtreeを選ぶ理由
開始はすばやく簡単です。初期費用はかかりません。
サービス依頼と専門家への見積依頼は無料です。
Kolabtree の作業範囲に同意する前に、専門家と要件を詳しく相談できます。
専門家と直接連携し、必要な成果を正しく得られます。
専門家を採用したらプロジェクトに資金を入れ、作業完了後に成果物を承認できます。
この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
プロジェクトを作成
★★★★★
☆☆☆☆☆
Dr. Ioannis L.に依頼
Switzerland

Pharmaceutical Industry professional with 5+ years of experience in drug development

プロフィール概要
専門分野
サービス
Writing Clinical Trial Documentation, Technical Writing, Copywriting, Newswriting
Research Market Research, User Research, Feasibility Study
Consulting Scientific and Technical Consulting, Regulatory Consulting
Data & AI Predictive Modeling, Statistical Analysis, Data Visualization, Data Processing, Data Insights
Product Development Formulation, Product Evaluation, Product Validation, Concept Development, Prototyping
職務経験

Principal Scientist

Novartis Pharma

9月 2021 - 現在

Senior Scientist II Modeling & Simulation | Clinical PBPK

Novartis Institutes for BioMedical Research Basel

5月 2020 - 現在

External PhD student at PharMetrX: Pharmacometrics & Computational Disease Modeling

Freie Universität Berlin Fachbereich Biologie Chemie Pharmazie

3月 2018 - 現在

Early Stage Research Fellow in PBPK modeling

Goethe University Frankfurt

3月 2017 - 3月 2020

学歴

Graduate certificate in Pharmacometrics & Computational Disease modeling (Clinical Pharmacy)

Freie Universität Berlin

2月 2018 - 現在

PhD Biopharmaceutics & Pharmacokinetics (Pharmaceutical Technology)

Goethe University Frankfurt

3月 2017 - 3月 2020

Pharmacometrics (Pharmacokinetics and Toxicokinetics)

Aix-Marseille Université

2016 - 2017

(Pharmacy)

National and Kapodistrian University of Athens

9月 2011 - 9月 2016

認定資格
  • Precision Oncology and Cancer Genomics

    Harvard medical school

    5月 2022 - 現在

  • Computational Disease Modeling

    University of Berlin

    6月 2021 - 現在

出版物
JOURNAL ARTICLE
Ioannis Loisios-Konstantinidis, Rodrigo Cristofoletti, Nikoletta Fotaki, David B. Turner, Jennifer Dressman(2020). Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. case example: Naproxen . European Journal of Pharmaceutical Sciences. 143. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 105170. Elsevier {BV}
Ioannis Loisios-Konstantinidis, Rafael L. M. Paraiso, Nikoletta Fotaki, Mark McAllister, Rodrigo Cristofoletti, Jennifer Dressman(2019). Application of the relationship between pharmacokinetics and pharmacodynamics in drug development and therapeutic equivalence: a PEARRL review . Journal of Pharmacy and Pharmacology. 71. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 699--723. Wiley
OTHER
Ioannis Loisios-Konstantinidis, Panteleimon D. Mavroudis, Panos Macheras(2020). Dynamical Aspects of Pharmacokinetic/Pharmacodynamic & Quantitative Systems Pharmacology Models . Approaching Complex Diseases. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 35--61. Springer International Publishing